CRBP
Corbus Pharmaceuticals Holding
NASDAQ: CRBP · HEALTHCARE · BIOTECHNOLOGY
$9.82
+0.00% today
Updated 2026-04-29
Market cap
$178.43M
P/E ratio
—
P/S ratio
169.88x
EPS (TTM)
$-5.90
Dividend yield
—
52W range
$6 – $21
Volume
0.2M
Corbus Pharmaceuticals Holding (CRBP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-769.00 | $-366715.00 | $-2.36M | $-4.65M | $-13.57M | $-27.80M | $-30.07M | $-45.72M | $-99.69M | $-48.18M | $-37.54M | $-36.10M | $-41.79M | $-64.49M |
| Capital expenditures | $0.00 | $0.00 | $64448.00 | $114037.00 | $353032.00 | $707429.00 | $2.30M | $2.74M | $484487.00 | $54172.00 | $13449.00 | $3.00 | $0.00 | $7000.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $26.00 | $6141.00 | $193120.00 | $1.15M | $3.16M | $5.69M | $7.61M | $11.98M | $12.46M | $9.48M | $5.72M | $3.47M | $6.14M | $6.29M |
| Free cash flow | $-769.00 | $-366715.00 | $-2.43M | $-4.76M | $-13.92M | $-28.50M | $-32.37M | $-48.46M | $-100.17M | $-48.24M | $-37.56M | $-36.10M | $-41.79M | $-64.50M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $5.96M | $6.08M | $2.82M | $47.50M | $-20.95M | $-10.00M | $54.70M | — | — | — | — | — |